Houten Frans Van bought ABSI once, on Dec 5, 2025
Director at Absci Corporation
SEC CIK 0001978991 · Filings on SEC.gov ↗
Houten Frans Van's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
1 filing since Dec 2025, newest first
About Houten Frans Van
Frans van Houten is the non-executive Chair of the Board at Absci Corporation (ABSI), having joined as an independent director in June 2023 and appointed Chair effective April 1, 2024.( He serves as a member of the Audit Committee, designated as an 'audit committee financial expert,' and Chair of the Nominating & Corporate Governance Committee, with the board affirming his independence under Nasdaq and SEC rules.( On December 5, 2025, he purchased 40,000 shares of ABSI at $3.72 per share, increasing his holdings to 63,320 shares.(
Van Houten, aged 64, brings extensive executive experience, including as CEO and Chair of Royal Philips NV from 2011 to 2022, where he led global transformation, and CEO of NXP Semiconductors NV from 2004 to 2008.( Earlier, he held managerial roles at Philips from 1986 to 2004.( He holds MSc and bachelor’s degrees in economics from Erasmus University Rotterdam.( Currently, he serves as an independent director at Novartis AG (since 2017), Castor EDC, Synthesis Health Inc., Affidea Group, and as Chair and Co-Founder of Graduate Entrepreneur.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.